Sustained Improvement of MYocardial Blood Flow by Intermittent PhosphoDiesterase 5 INhibition in REfractory Coronary ArterY Disease Suggests Enhanced Angiogenesis (SYDNEY)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Vardenafil (Primary)
- Indications Angina pectoris; Coronary artery disease; Myocardial ischaemia
- Focus Biomarker; Therapeutic Use
- Acronyms SYDNEY
Most Recent Events
- 03 Aug 2011 New trial record
- 01 Aug 2011 Biomarkers information updated